Načítá se...
Circulating Interleukin-6 is Associated with Disease Progression, but not Cachexia in Pancreatic Cancer
BACKGROUND: Cachexia is a wasting syndrome characterized by involuntary loss of >5% body weight due to depletion of adipose and skeletal muscle mass. In cancer, the pro-inflammatory cytokine interleukin-6 (IL-6) is considered a mediator of cachexia and a potential biomarker, but the relationship...
Uloženo v:
| Vydáno v: | Pancreatology |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6613190/ https://ncbi.nlm.nih.gov/pubmed/30497874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pan.2018.11.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|